Navigation Links
Securing the future of Europe's biological data resources

In a contract signed today, the European Commission has awarded 4.5 million to a pan-European consortium to decide upon the best way to unite Europes biological data resources into a sustainable, integrative bioinformatics network for the life sciences. The European Life-science Infrastructure for Biological Information (ELIXIR) project is led by the European Molecular Biology Laboratorys European Bioinformatics Institute (EMBL-EBI) and involves 32 partners from 13 countries. The consortium ultimately aims to establish a sustainably funded infrastructure for biological information in Europe, to support innovation in life science research, knowledge generation and its translation to medicine, the environment, the bio-industries and society.

Since the 1980s, the storage mechanism for biological information has gone from being an individuals notebook and published academic papers to open source databases of integrated information exchanged worldwide on a daily basis. This information and the databases that make it available to scientists around the world are an indispensable resource for modern biology. Yet commonly these resources are dependent on insecure or short term funding, meaning that the valuable data they contain and provide access to, are jeopardised when funding ends.

ELIXIR aims to protect the existing and future data held in biological data resources. The project will work to provide a European infrastructure for optimal information storage, access and integration supported by a secure funding mechanism. "Under the Framework Programme for Research, the European Commission provides support to the preparatory phase for the construction of new research infrastructures, commented Mr Robert-Jan Smits, Director of Directorate B (European Research Area: Research Programmes and Capacity) at DG Research of the European Commission. This will help catalyse the efforts and resources needed to build and ensure the sustainability of large-scale, word-class infrastructures needed by Europe's research communities." In this way, the longevity of Europes central molecular data resources will be guaranteed.

The development of such a network is a strategic step in maintaining the global position of Europe as a leader in scientific research. The biological sciences are delivering benefits that contribute to advances in our society, says EMBL-EBI director and ELIXIR coordinator Janet Thornton. Developing a securely funded, integrative infrastructure will give Europe one voice in the global community, meaning that we can make connections and realise those benefits more quickly by working together, she concludes.


Contact: Louisa Wright
European Molecular Biology Laboratory

Related biology news :

1. Great Plains historical stability vulnerable to future changes
2. Gene may hold key to future cancer hope
3. DOE publishes update of plan: Facilities for the Future of Science: A 20-Year Outlook
4. NASA technology helps predict and prevent future pandemic outbreaks
5. Sunbathing tree frogs future under a cloud
6. Methane from microbes: a fuel for the future
7. Setting a course for the future of tissue engineering
8. Air quality forecasts see future in space
9. Oceans Past: A Guide to Oceans Future
10. Building the future -- 21st century nano tools to repair the nervous system
11. Climate change in the Baltic Sea basin -- past, present and future
Post Your Comments:
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
(Date:11/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), the ... entry into the automotive market with a comprehensive and ... of consumer electronics human interface innovation. Synaptics, industry-leading touch ... the automotive industry and will be implemented in numerous ... , Japan , and ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing of ... team leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman ... AngelList early in their initial angel funding process. Now, they are paying it ... to make early stage investments in the microbiome space. In this, they ...
Breaking Biology Technology: